Detecting At-Risk Alzheimer’s Disease Cases

While APOE ɛ4 is the major genetic risk factor for Alzheimer’s disease (AD), amyloid dysmetabolism is an initial or early event predicting clinical disease and is an important focus for secondary intervention trials. To improve identification of cases with increased AD risk, we evaluated recruitment...

Descripción completa

Detalles Bibliográficos
Autores principales: Fladby, Tormod, Pålhaugen, Lene, Selnes, Per, Waterloo, Knut, Bråthen, Geir, Hessen, Erik, Almdahl, Ina Selseth, Arntzen, Kjell-Arne, Auning, Eirik, Eliassen, Carl Fredrik, Espenes, Ragna, Grambaite, Ramune, Grøntvedt, Gøril Rolfseng, Johansen, Krisztina Kunszt, Johnsen, Stein Harald, Kalheim, Lisa Flem, Kirsebom, Bjørn-Eivind, Müller, Kai Ivar, Nakling, Arne Exner, Rongve, Arvid, Sando, Sigrid Botne, Siafarikas, Nikias, Stav, Ane Løvli, Tecelao, Sandra, Timon, Santiago, Bekkelund, Svein Ivar, Aarsland, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611830/
https://www.ncbi.nlm.nih.gov/pubmed/28826181
http://dx.doi.org/10.3233/JAD-170231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611830/
https://www.ncbi.nlm.nih.gov/pubmed/28826181
http://dx.doi.org/10.3233/JAD-170231

Ejemplares similares